宫腔镜手术子宫颈预处理临床实践指南

2020-12-30 中华医学会妇产科学分会 中华妇产科杂志.2020.55(12):813-818.

宫腔镜以其经自然腔道施术、在诊断及治疗子宫腔疾病的同时能够保留子宫、保留生育功能,成为子宫腔疾病的首选诊疗方法。由于非妊娠期子宫颈具有坚韧、难以扩张的特殊组织学特点,良好的子宫颈预处理已经成为实施宫腔

中文标题:

宫腔镜手术子宫颈预处理临床实践指南

发布日期:

2020-12-30

简要介绍:

宫腔镜以其经自然腔道施术、在诊断及治疗子宫腔疾病的同时能够保留子宫、保留生育功能,成为子宫腔疾病的首选诊疗方法。由于非妊娠期子宫颈具有坚韧、难以扩张的特殊组织学特点,良好的子宫颈预处理已经成为实施宫腔镜手术减少子宫颈裂伤、空气栓塞及子宫穿孔等并发症的重要步骤和安全保障。目前,虽然国内外对宫腔镜手术子宫颈预处理不乏临床研究报道,但缺乏客观统一的评判标准,且研究观点分散。中华医学会妇产科学分会妇科内镜学组专家结合国内外子宫颈预处理的最新循证医学证据和我国的宫腔镜手术临床实践制定本指南,旨在指导宫腔镜手术子宫颈预处理的临床操作规范,减少手术并发症,提高手术安全性。

下载附件:

(因为版权问题,不支持下载)

评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1006946, encodeId=87ed10069464f, content=资料比较好,及时,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d38d5382839, createdName=ms4000001938598864, createdTime=Wed Aug 11 13:47:01 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997468, encodeId=1a7499e4683e, content=好诶!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/6e0936d018c24637ab01316e2050c201/ce8d7ce69c034d1ab46164b72534f81f.jpg, createdBy=2df05544188, createdName=小楠23, createdTime=Thu Jul 08 09:46:51 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975868, encodeId=c3f09e586859, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:55:04 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975866, encodeId=d57d9e5866a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:54:40 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969647, encodeId=7eb696964e44, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95c85216809, createdName=1476fc5em34暂无昵称, createdTime=Sun May 30 16:02:01 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-08-11 ms4000001938598864

    资料比较好,及时,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1006946, encodeId=87ed10069464f, content=资料比较好,及时,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d38d5382839, createdName=ms4000001938598864, createdTime=Wed Aug 11 13:47:01 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997468, encodeId=1a7499e4683e, content=好诶!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/6e0936d018c24637ab01316e2050c201/ce8d7ce69c034d1ab46164b72534f81f.jpg, createdBy=2df05544188, createdName=小楠23, createdTime=Thu Jul 08 09:46:51 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975868, encodeId=c3f09e586859, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:55:04 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975866, encodeId=d57d9e5866a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:54:40 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969647, encodeId=7eb696964e44, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95c85216809, createdName=1476fc5em34暂无昵称, createdTime=Sun May 30 16:02:01 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-07-08 小楠23

    好诶!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1006946, encodeId=87ed10069464f, content=资料比较好,及时,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d38d5382839, createdName=ms4000001938598864, createdTime=Wed Aug 11 13:47:01 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997468, encodeId=1a7499e4683e, content=好诶!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/6e0936d018c24637ab01316e2050c201/ce8d7ce69c034d1ab46164b72534f81f.jpg, createdBy=2df05544188, createdName=小楠23, createdTime=Thu Jul 08 09:46:51 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975868, encodeId=c3f09e586859, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:55:04 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975866, encodeId=d57d9e5866a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:54:40 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969647, encodeId=7eb696964e44, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95c85216809, createdName=1476fc5em34暂无昵称, createdTime=Sun May 30 16:02:01 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-06-22 福尔摩妮

    厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1006946, encodeId=87ed10069464f, content=资料比较好,及时,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d38d5382839, createdName=ms4000001938598864, createdTime=Wed Aug 11 13:47:01 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997468, encodeId=1a7499e4683e, content=好诶!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/6e0936d018c24637ab01316e2050c201/ce8d7ce69c034d1ab46164b72534f81f.jpg, createdBy=2df05544188, createdName=小楠23, createdTime=Thu Jul 08 09:46:51 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975868, encodeId=c3f09e586859, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:55:04 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975866, encodeId=d57d9e5866a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:54:40 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969647, encodeId=7eb696964e44, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95c85216809, createdName=1476fc5em34暂无昵称, createdTime=Sun May 30 16:02:01 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-06-22 福尔摩妮

    厉害

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1006946, encodeId=87ed10069464f, content=资料比较好,及时,, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d38d5382839, createdName=ms4000001938598864, createdTime=Wed Aug 11 13:47:01 CST 2021, time=2021-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997468, encodeId=1a7499e4683e, content=好诶!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210708/6e0936d018c24637ab01316e2050c201/ce8d7ce69c034d1ab46164b72534f81f.jpg, createdBy=2df05544188, createdName=小楠23, createdTime=Thu Jul 08 09:46:51 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975868, encodeId=c3f09e586859, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:55:04 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975866, encodeId=d57d9e5866a0, content=厉害, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201203/23c7fab364194717836769d96a50cdde/783e78a2b4a4410c9dae7e959ba1c77c.jpg, createdBy=1efd2552192, createdName=福尔摩妮, createdTime=Tue Jun 22 17:54:40 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969647, encodeId=7eb696964e44, content=学习了,很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95c85216809, createdName=1476fc5em34暂无昵称, createdTime=Sun May 30 16:02:01 CST 2021, time=2021-05-30, status=1, ipAttribution=)]
    2021-05-30 1476fc5em34暂无昵称

    学习了,很好

    0

拓展阅读

2020 ACOG委员会意见:宫腔镜在宫内病理学诊断和治疗中的应用(No.800)

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2020-03-20

宫腔镜诊疗麻醉管理的专家共识

中国心胸血管麻醉学会 · 2020-11-30

FDA:用于灭菌的永久性宫腔镜置入输卵管植入物的标签

美国食品和药品监督管理局(FDA,Food and Drug Administration) · 2021-10-01

2021 ISGE指南:宫腔镜子宫肌瘤切除术

国际妇科内镜学会(ISGE,International Society for Gynecologic Endoscopy) · 2021-12-01